429 related articles for article (PubMed ID: 25737398)
1. Biomarkers of cognitive decline in Parkinson's disease.
Lin CH; Wu RM
Parkinsonism Relat Disord; 2015 May; 21(5):431-43. PubMed ID: 25737398
[TBL] [Abstract][Full Text] [Related]
2. Markers of cognitive decline in PD: The case for heterogeneity.
Monchi O; Hanganu A; Bellec P
Parkinsonism Relat Disord; 2016 Mar; 24():8-14. PubMed ID: 26774536
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.
Svenningsson P; Westman E; Ballard C; Aarsland D
Lancet Neurol; 2012 Aug; 11(8):697-707. PubMed ID: 22814541
[TBL] [Abstract][Full Text] [Related]
4. What can biomarkers tell us about cognition in Parkinson's disease?
Mollenhauer B; Rochester L; Chen-Plotkin A; Brooks D
Mov Disord; 2014 Apr; 29(5):622-33. PubMed ID: 24757111
[TBL] [Abstract][Full Text] [Related]
5. Neuroimaging studies of different cognitive profiles in Parkinson's disease.
Monchi O; Degroot C; Mejia-Constain B; Bruneau MA
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S77-9. PubMed ID: 22166462
[TBL] [Abstract][Full Text] [Related]
6. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for cognitive dysfunction in Parkinson's disease.
Kalia LV
Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S19-S23. PubMed ID: 28781202
[TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of cognitive impairment in Parkinson's disease.
Goldman JG; Weintraub D
Mov Disord; 2015 Sep; 30(11):1471-89. PubMed ID: 26297863
[TBL] [Abstract][Full Text] [Related]
10. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
[TBL] [Abstract][Full Text] [Related]
11. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study.
Janvin CC; Aarsland D; Larsen JP
J Geriatr Psychiatry Neurol; 2005 Sep; 18(3):149-54. PubMed ID: 16100104
[TBL] [Abstract][Full Text] [Related]
12. Characterizing Cognitive Impairment in Parkinson's Disease.
Bailey M; Goldman JG
Semin Neurol; 2017 Apr; 37(2):167-175. PubMed ID: 28511257
[TBL] [Abstract][Full Text] [Related]
13. Dysautonomia and cognitive dysfunction in Parkinson's disease.
Poewe W
Mov Disord; 2007 Sep; 22 Suppl 17():S374-8. PubMed ID: 18175399
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment in Parkinson's disease.
Cosgrove J; Alty JE; Jamieson S
Postgrad Med J; 2015 Apr; 91(1074):212-20. PubMed ID: 25814509
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of executive function impairment in Parkinson's disease patients without dementia.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
J Int Neuropsychol Soc; 2010 Mar; 16(2):268-77. PubMed ID: 20003582
[TBL] [Abstract][Full Text] [Related]
16. Profile of cognitive impairment in Parkinson's disease.
Watson GS; Leverenz JB
Brain Pathol; 2010 May; 20(3):640-5. PubMed ID: 20522089
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
Marek K; Jennings D; Tamagnan G; Seibyl J
Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
[TBL] [Abstract][Full Text] [Related]
18. New markers in Parkinson's disease.
Bougea A
Adv Clin Chem; 2020; 96():137-178. PubMed ID: 32362317
[TBL] [Abstract][Full Text] [Related]
19. [Cognition deterioration in Parkinson's disease: associated risk factors].
Errea JM; Ara JR
Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.
Delgado-Alvarado M; Gago B; Navalpotro-Gomez I; Jiménez-Urbieta H; Rodriguez-Oroz MC
Mov Disord; 2016 Jun; 31(6):861-81. PubMed ID: 27193487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
